« PreviousNext »Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 1 , Pages 40-48, January 2010
Volume 19, Issue 1 , Pages 40-48, January 2010
Time of Day, Outcome, and Response to Thrombolytic Therapy: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial Experience
To access this article, please choose from the options below
Supported by the National Institute of Neurological Disorders and Stroke (N01-NS-02383, N01-NS-02374, N01-NS-02377, N01-NS-02381, N01-NS-02379, N01-NS-02373, N01-NS-02378, N01-NS-02376, N01-NS-02380, K24N543992, and R01-NS-38905).
PII: S1052-3057(09)00064-0
doi:10.1016/j.jstrokecerebrovasdis.2009.03.006
© 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.
« PreviousNext »Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 1 , Pages 40-48, January 2010
Volume 19, Issue 1 , Pages 40-48, January 2010
